查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387364

CRP（C 反应蛋白）测试市场报告：2030 年趋势、预测与竞争分析

C Reactive Protein Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

CRP（C 反应蛋白）检测的趋势与预测

预计到 2030 年，全球 CRP 检测市场将达到约 47 亿美元，2024 年至 2030 年年复合成长率为 3.1%。这个市场的主要驱动因素是老年人口的增加、护理点设备的采用增加以及医疗服务需求的增加。全球CRP检测市场前景广阔，糖尿病、类风湿性关节炎、心血管疾病、发炎性肠道疾病市场蕴藏机会。

CRP 测试市场洞察

Lucintel 预测，免疫比浊法在预测期内将继续成为最大的细分市场，因为它可以灵敏地测量各种 CRP 值。

在这个市场中，由于心血管疾病的快速增加以及对心血管疾病诊断和监测的需求不断增长，心血管疾病仍将是最大的细分市场。

由于该地区发炎疾病的流行、不健康的生活方式的改变以及高昂的医疗保健支出，在预测期内，北美将继续成为最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和业务风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球CRP测试市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球CRP测试市场趋势（2018-2023）与预测（2024-2030）
  • 按分析类型分類的全球 CRP 测试市场
    • ELISA
    • 化学冷光免疫测量
    • 免疫比浊法
    • 其他的
  • 按应用分類的全球 CRP 测试市场
    • 糖尿病
    • 类风湿性关节炎
    • 循环系统疾病
    • 发炎性肠道疾病
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 按地区分類的全球 CRP 测试市场
  • 北美CRP检测市场
  • 欧洲CRP测试市场
  • 亚太CRP测试市场
  • 其他地区CRP检测市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按分析类型分類的全球 CRP 测试市场成长机会
    • 全球 CRP 测试市场成长机会（按应用）
    • 按地区分類的全球 CRP 测试市场成长机会
  • 全球CRP检测市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球 CRP 检测市场的产能
    • 全球CRP检测市场的合併、收购与合资
    • 认证和许可

第7章主要企业概况

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech
简介目录

C Reactive Protein Testing Trends and Forecast

The future of the global C reactive protein testing market looks promising with opportunities in the diabetes, rheumatoid arthritis, cardiovascular disease, and inflammatory bowel disease markets. The global C reactive protein testing market is expected to reach an estimated $4.7 billion by 2030 with a CAGR of 3.1% from 2024 to 2030. The major drivers for this market are increasing geriatric population, growing adoption of point-of-care devices, and rising demand for healthcare services.

A more than 150-page report is developed to help in your business decisions.

C Reactive Protein Testing by Segment

The study includes a forecast for the global C reactive protein testing by assay type, application, and region.

C Reactive Protein Testing Market by Assay Type [Shipment Analysis by Value from 2018 to 2030]:

  • Enzyme-Linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Immunoturbidimetric Assay
  • Others

C Reactive Protein Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diabetes
  • Rheumatoid Arthritis
  • Cardiovascular Disease
  • Inflammatory Bowel Disease
  • Others

C Reactive Protein Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of C Reactive Protein Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies C reactive protein testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the C reactive protein testing companies profiled in this report include-

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

C Reactive Protein Testing Market Insights

Lucintel forecasts that immunoturbidimetric assay will remain the largest segment over the forecast period as it provides high sensitivity for measuring a wide range of CRP levels.

Within this market, cardiovascular disease will remain the largest segment due to surge in cardiovascular diseases and growing need to diagnose and monitor cardiovascular diseases.

North America will remain the largest region over the forecast period due to growing prevalence of inflammatory diseases, change in unhealthy lifestyle, and high healthcare expenditure in the region.

Features of the Global C Reactive Protein Testing Market

Market Size Estimates: C reactive protein testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: C reactive protein testing market size by assay type, application, and region in terms of value ($B).

Regional Analysis: C reactive protein testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different assay types, applications, and regions for the C reactive protein testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the C reactive protein testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the C reactive protein testing market size?

Answer: The global C reactive protein testing market is expected to reach an estimated $4.7 billion by 2030.

Q2. What is the growth forecast for C reactive protein testing market?

Answer: The global C reactive protein testing market is expected to grow with a CAGR of 3.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the C reactive protein testing market?

Answer: The major drivers for this market are increasing geriatric population, growing adoption of point-of-care devices, and rising demand for healthcare services.

Q4. What are the major segments for C reactive protein testing market?

Answer: The future of the C reactive protein testing market looks promising with opportunities in the diabetes, rheumatoid arthritis, cardiovascular disease, and inflammatory bowel disease markets.

Q5. Who are the key C reactive protein testing market companies?

Answer: Some of the key C reactive protein testing companies are as follows:

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

Q6. Which C reactive protein testing market segment will be the largest in future?

Answer: Lucintel forecasts that immunoturbidimetric assay will remain the largest segment over the forecast period as it provides high sensitivity for measuring a wide range of CRP levels.

Q7. In C reactive protein testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing prevalence of inflammatory diseases, change in unhealthy lifestyle, and high healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the C reactive protein testing market by assay type (enzyme-linked immunosorbent assay, chemiluminescence immunoassay, immunoturbidimetric assay, and others), application (diabetes, rheumatoid arthritis, cardiovascular disease, inflammatory bowel disease, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global C Reactive Protein Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global C Reactive Protein Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global C Reactive Protein Testing Market by Assay Type
    • 3.3.1: Enzyme-Linked Immunosorbent Assay
    • 3.3.2: Chemiluminescence Immunoassay
    • 3.3.3: Immunoturbidimetric Assay
    • 3.3.4: Others
  • 3.4: Global C Reactive Protein Testing Market by Application
    • 3.4.1: Diabetes
    • 3.4.2: Rheumatoid Arthritis
    • 3.4.3: Cardiovascular Disease
    • 3.4.4: Inflammatory Bowel Disease
    • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global C Reactive Protein Testing Market by Region
  • 4.2: North American C Reactive Protein Testing Market
    • 4.2.2: North American C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.3: European C Reactive Protein Testing Market
    • 4.3.1: European C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.3.2: European C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.4: APAC C Reactive Protein Testing Market
    • 4.4.1: APAC C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.4.2: APAC C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.5: ROW C Reactive Protein Testing Market
    • 4.5.1: ROW C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.5.2: ROW C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global C Reactive Protein Testing Market by Assay Type
    • 6.1.2: Growth Opportunities for the Global C Reactive Protein Testing Market by Application
    • 6.1.3: Growth Opportunities for the Global C Reactive Protein Testing Market by Region
  • 6.2: Emerging Trends in the Global C Reactive Protein Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global C Reactive Protein Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global C Reactive Protein Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Danaher
  • 7.4: Quest Diagnostics
  • 7.5: Siemens Healthineers
  • 7.6: Abbott
  • 7.7: Merck KGaAA
  • 7.8: Zoetis
  • 7.9: Ortho Clinical Diagnostics
  • 7.10: Getein Biotech